BSX Boston Scientific Corporation

NYSE
$45.05

Boston Scientific Corporation (BSX) Insider Activity

What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.

Insider signal In line Selling ran in line with BSX's own trailing one-year pace, with 100% of sale value under a prearranged plan.
Cluster activity 1 buyer in the last 30 days 4 buyers in the last 90 days 0 sellers in the last 90 days
Insiders buying
5
10 transactions
Insiders selling
4
11 transactions
Purchases
$10.0M
206,362 shares
Sales
$29.3M
303,996 shares
Net activity
-$19.2M
purchases less sales

How much of that selling was preplanned? 100% planned / 0% discretionary

10b5-1 plan sales $29.3M 11 transactions · 303,996 shares
Discretionary sales $0 0 transactions · 0 shares

Largest single sale: $14.9M.

Where they traded

Buy Sell Dot area is proportional to transaction value.

Last open-market purchase: August 25, 2026 , by Morano Susan E .

Recent open-market activity

Date Insider Role Action Shares Price Value Held after
Morano Susan E Director Buy 2,040 $49.22 $100.4K 13,784
Habiger David C Director Buy 2,100 $47.59 $99.9K 17,160
Habiger David C Director Buy 140 $48.59 $6.8K 15,060
Mahoney Michael F Chairman, President & CEO Buy 186,240 $48.33 $9.0M 1,590,024
Habiger David C Director Buy 1,042 $48.07 $50.1K 14,920
LUDWIG EDWARD J Director Buy 5,000 $45.48 $227.4K 30,359
LUDWIG EDWARD J Director Buy 3,580 $56.68 $202.9K 25,359
Habiger David C Director Buy 2,250 $55.92 $125.8K 13,878
Pegus Cheryl Director Buy 1,770 $56.49 $100.0K 1,770
Habiger David C Director Buy 2,200 $56.95 $125.3K 11,628
Mahoney Michael F 2 fills Chairman, President & CEO Sell 10b5-1 160,901 $93.49 $15.0M 1,571,436 −9.3% of holding
Butcher Arthur C EVP& Grp Pres, MedSurg & APAC Sell 10b5-1 17,313 $101.55 $1.8M 23,600 −42.3% of holding
Zane Ellen M Director Sell 10b5-1 12,891 $98.28 $1.3M 24,134 −34.8% of holding
Fitzgerald Joseph Michael 3 fills EVP & Group Pres, Cardiology Sell 10b5-1 50,000 $99.47 $5.0M 224,742 −18.2% of holding
Zane Ellen M Director Sell 10b5-1 2,901 $102.24 $296.6K 24,134 −10.7% of holding
Zane Ellen M Director Sell 10b5-1 9,990 $101.13 $1.0M 27,035 −27% of holding
Fitzgerald Joseph Michael 2 fills EVP & Group Pres, Cardiology Sell 10b5-1 50,000 $98.47 $4.9M 220,097 −18.5% of holding

Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.